Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical propranolol 1% for pyogenic granulomas
2009-014572-22Phase 2Completed
- Sponsor
- Sant'Orsola-Malpighi University Hospital
- Start
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of propranolol in lobular capillary hemangioma (PG), sponsored by Sant'Orsola-Malpighi University Hospital. Primary endpoint: Efficacy of topical propranolol 1% in pyogenic granulomas. Started Jul 2010; status: completed.
02
Drugs
propranolol
03
Conditions
lobular capillary hemangioma (PG)
Beyond the preview
Go deeper on 2009-014572-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014572-22.